UGC Approved Journal no 63975(19)
New UGC Peer-Reviewed Rules

ISSN: 2349-5162 | ESTD Year : 2014
Volume 12 | Issue 10 | October 2025

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 12 Issue 2
February-2025
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2502575


Registration ID:
555779

Page Number

f536-f553

Share This Article


Jetir RMS

Title

QUALITY BY DESIGN: PHARMACEUTICAL DEVELOPMENT

Abstract

This review explains the concept of QbD and describes its objectives and applications in various fields. Although Quality by Design (QbD) is the best way to ensure the quality of all pharmaceutical products, it poses a significant challenge to the pharmaceutical industry because its processes are set in stone, and materials and processes are inherently variable. Quality by Design (QbD) is a new concept for the development of high-quality pharmaceutical products. During the design and development of a product, it is crucial to define the desired product performance profile (Target Product Profile, Target Product Quality Profile ) as well as the critical quality attributes that must be present (CQA). We may create the product formulation and procedure to meet the product qualities. This prompts an understanding of the influence of raw. Awareness of principles and expectations, as well as a standard vocabulary, are required as the pharmaceutical sector works toward the adoption of pharmaceutical QbD. This knowledge will make better communication between those involved in risk-based medication development and drug application review possible.

Key Words

QbD, CPP, CQA, QTPP.

Cite This Article

"QUALITY BY DESIGN: PHARMACEUTICAL DEVELOPMENT ", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.12, Issue 2, page no.f536-f553, February-2025, Available :http://www.jetir.org/papers/JETIR2502575.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"QUALITY BY DESIGN: PHARMACEUTICAL DEVELOPMENT ", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.12, Issue 2, page no. ppf536-f553, February-2025, Available at : http://www.jetir.org/papers/JETIR2502575.pdf

Publication Details

Published Paper ID: JETIR2502575
Registration ID: 555779
Published In: Volume 12 | Issue 2 | Year February-2025
DOI (Digital Object Identifier):
Page No: f536-f553
Country: Vasind (Thane), Maharastra, India .
Area: Pharmacy
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

000168

Print This Page

Current Call For Paper

Jetir RMS